Consideration of sex as a biological variable over the history of the 5xFAD Alzheimer’s Disease mouse model
Authors:
Open Access
- 17 December 2025
- journal article
- Published by Springer Nature in Biology of Sex Differences
- Vol. 16 (1) , 105
Abstract
Background: Women are nearly twice as likely to be diagnosed with Alzheimer’s Disease (AD) over their lifetime. However, historically, preclinical studies utilizing AD rodent models to define new therapeutic targets in AD treatment have neglected to consider the confounding influence of subject sex leading to a lack of mechanistic insight into the biological underpinnings of sex bias in AD. Methods: Here, we tracked choice of subject sex over the twenty-year history of the 5xFAD mouse, one of the most frequently cited pre-clinical AD models. We analyzed 1,330 primary research articles indexed on PubMed and recorded information provided regarding subject sex and/or as a rationale for not including datasets separated by sex, if noted. Trends were then plotted as a function of time ending in December 2024. Results: In the last 15 years, the number of published manuscripts on the 5xFAD model omitting information on subject sex has progressively declined. However, the proportion of studies utilizing either males only (29%) or combining data from both sexes (24%) far surpasses studies acknowledging sex as a biological variable (SABV) (< 12%) with no significant changes noted over time. On average, the ratio of male only: female only studies of 5xFAD mice hovered around 2:1. The most frequently cited reason for omitting sex-based analyses was either a lack of sex differences found (29%), accelerated development of plaque burden in 5xFAD females (17%), or the possibility of within- or between-sex variability (15%). Mention of SABV has steadily increased in studies utilizing 5xFAD mice peaking at ~ 30% of manuscripts published in 2024. However, two key confounds in the 5xFAD model, including the potential impact of an estrogen response element (ERE) and parental imprinting in the Thy1 promoter driving transgene expression, have been largely ignored. Conclusions: The 5xFAD model represents a compelling example of how neglecting to recognize the impact of biological sex on neural function can compromise study design and data interpretation. Given sex-dependent Thy1 promoter regulation may skew phenotypic outcomes, investigators should judiciously interpret sex differences observed in any AD mouse utilizing the Thy1 promoter to drive transgene expression.Keywords
Funding Information
- National Institutes of Health (NIH T32NS007421)
- University of Iowa (Lulu Merle Johnson Recruitment Fellowship)
- Brain and Behavior Research Foundation
This publication has 125 references indexed in Scilit:
- 2024 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2024
- Gender differences in Alzheimer's may be associated with TLR4‐LYN expression in damage associated microglia and neuronal phagocytosisJournal of Cellular Physiology, 2022
- Global estimates on the number of persons across the Alzheimer's disease continuumAlzheimer's & Dementia, 2022
- Sex Mediates Relationships Between Regional Tau Pathology and Cognitive DeclineAnnals of Neurology, 2020
- Reproductive period and dementia: A 44‐year longitudinal population study of Swedish womenAlzheimer's & Dementia, 2020
- Reduced social investigation and increased injurious behavior in transgenic 5xFAD miceJournal of Neuroscience Research, 2020
- CD11a expression distinguishes infiltrating myeloid cells from plaque‐associated microglia in Alzheimer's diseaseGlia, 2018
- Sex‐biased hippocampal pathology in the 5XFAD mouse model of Alzheimer's disease: A multi‐omic analysisJournal of Comparative Neurology, 2018
- Prevalence of Cerebral Amyloid Pathology in Persons Without DementiaJAMA, 2015
- Sex Differences in the Clinical Manifestations of Alzheimer Disease PathologyArchives of General Psychiatry, 2005